A peripheral artery disease (PAD) patient CT scan showing blockages in the femoral arteries in the legs with collateral flow in the leg on the right.
News | Stents Bioresorbable
First-In-Human Use Reported for Bioresorbable Efemoral Vascular Scaffold System

December 16, 2020 — Efemoral Medical announced the first-in-human (FIH) use of the its Efemoral bioresorbable vascular ...

Home December 16, 2020
Home
Corpath GRX interventional cardiology robotic system is comprised of two different components: 1. The control console. 2. The bedside unit.
News | Robotic Systems
Corindus Launches technIQ 1 Smart Procedural Automation Series for CorPath GRX Cath lab Robotic System

December 16, 2020 — Corindus, A Siemens Healthineers company and a leading developer of vascular robotics, began its ...

Home December 16, 2020
Home
The Digisonics' cardiovascular information system (CVIS) system.
News | Cardiovascular Information Systems (CVIS)
Intelerad Acquires Digisonics to Expand its Enterprise Imaging Workflow 

December 16, 2020 - Intelerad Medical Systems, a provider of enterprise imaging workflow solutions, has acquired ...

Home December 16, 2020
Home
Videos | FFR Technologies
VIDEO: Example of the Medis QFR Angiography Image Derived FFR System

This is an example of the Medis Medical Imaging Quantitative Flow Ratio (QFR) system that offers a fractional flow ...

Home December 16, 2020
Home
Videos | Robotic Systems
VIDEO: Corindus CorPath Robotic PCI System For The Cardiac Cath Lab

This is an example of the Siemens Corindus CorPath Cath lab robotic system being used for a percutaneous coronary ...

Home December 16, 2020
Home
The Medis Quantitative Flow Ratio (QFR) is a novel, non-invasive, angiography-based physiologic FFR-like assessment of the presence and extent of coronary artery disease.
News | FFR Technologies
Acist Medical Partners With Medis to Distribute Angiography Image Derived FFR Quantification System

December 16, 2020 – Acist Medical Systems Inc. announced a formal distribution partnership with Medis Medical Imaging to ...

Home December 16, 2020
Home
COVID-19 has posed challenges for physicians whose cardiac patients are at-risk and reluctant to schedule an office visit. Floyd Russak, M.D., of Russak Personalized Medicine, an internal medicine physician practicing in Greenwood Village, Colo., manages many cardiac patients who do not have ready access to a cardiologist
Sponsored Content | Feature | Wearables
Cardiac Monitoring in the Time of COVID-19: Next Generation Wearable ECG Technology Comes into Its Own

COVID-19 has posed challenges for physicians whose cardiac patients are at-risk and reluctant to schedule an office ...

Home December 15, 2020
Home
Webinar | Information Technology
WEBINAR: Understanding the Benefits of Single-Database Cardiology

To improve efficiencies in your cardiology department, you need technology to streamline workflows, reduce redundant ...

Home December 15, 2020
Home
Foldax Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted an investigational device exemption (IDE) so the company to initiate a U.S. clinical study of its Tria biopolymer mitral surgical heart valve.
News | Heart Valve Technology
Foldax to Initiate FDA Clinical Study of Biopolymer Mitral Heart Valve

December 14, 2020 - Foldax Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted an ...

Home December 14, 2020
Home
The U.S. Food and Drug Administration (FDA) issued the first emergency use authorization (EUA) Dec, 12 for the COVID-19 vaccine submitted by Pfizer Inc. in partnership with BioNTech Manufacturing GmbH. It is the first mRNA vaccine to gain an FDA clearance and the first COVID vaccine to gain FDA clearance.  #COVID #COVID19 #SARSCoV2 #vaccine #COVIDVaccine
Feature | Coronavirus (COVID-19) | Dave Fornell, Editor
FDA Clears First COVID-19 Vaccine Under an Emergency Use Authorization

December 14, 2020 — The U.S. Food and Drug Administration (FDA) issued the first emergency use authorization (EUA) for ...

Home December 14, 2020
Home
SoniVie, an Israeli company developing the Therapeutic Intra-Vascular Ultrasound (TIVUS) System to treat a variety of hypertensive disorders, announced that it has been granted Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA). The  TIVUS System for renal artery denervation treats resistant hypertension, which is defined as blood pressure that remains above 140/90 mmHg despite use of three antihypertensive medications of different classes at the best tolerated doses.
News | Renal Denervation
FDA Grants Breakthrough Device Designation for the TIVUS Renal Artery Denervation System

December 9, 2020 — SoniVie, an Israeli company developing the Therapeutic Intra-Vascular Ultrasound (TIVUS) System to ...

Home December 09, 2020
Home
Videos | Coronavirus (COVID-19)
VIDEO: What Are The Long-term Cardiac Impacts of COVID-19 Infection

Todd Hurst, M.D., a cardiologist at Banner University Medicine Heart Institute, and an associate professor at the ...

Home December 07, 2020
Home
Videos | EP Lab
VIDEO: Early Ablation Improved Outcomes in Atrial Fibrillation Patients

Oussama Wazni, M.D., section head, electrophysiology, Cleveland Clinic, discusses the results of the recent STOP AF ...

Home December 04, 2020
Home
The Spectrum Dynamics Veriton-CT64 Digital SPECT/CT nuclear imaging system has its SPECT detectors housed in extendable arms to get as close to the patent's chest as possible to improve cardiac perfusion image quality. #RSNA2020 #RSNA20 #RSNA
News | Nuclear Imaging
Spectrum Dynamics Receives Approval From Health Canada for Veriton-CT64 Digital SPECT/CT

December 4, 2020 — Spectrum Dynamics Medical, Inc., has received Canadian Medical Device License from Health Canada for ...

Home December 04, 2020
Home
Feature
The DAIC November-December 2020 Digital Edition

View the November-December 2020 digital edition of Diagnostic and Interventional Cardiology (DAIC) magazine, include ...

Home December 03, 2020
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now